PSTX241220C5000
- 4.30
- 0.000.00%
Poseida Therapeutics Newsroom
10 Health Care Stocks With Whale Alerts In Today's Session
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Should You Buy Poseida Therapeutics, Inc. (PSTX) After Golden Cross?
Insider Sale: Executive Chairman of $PSTX (PSTX) Sells 30,000 Shares
Wall Street Analysts Think Poseida Therapeutics (PSTX) Could Surge 49.25%: Read This Before Placing a Bet
A Quick Look at Today's Ratings for Poseida Therapeutics(PSTX.US), With a Forecast Between $9 to $9
Poseida Therapeutics Downgraded to Neutral From Overweight at Cantor Fitzgerald
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Poseida Therapeutics Cut to Market Perform From Outperform by William Blair
Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com
Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk
US Stocks Mixed; Best Buy Posts Downbeat Earnings
Shareholder Alert: Ademi LLP Investigates Whether Poseida Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Poseida Therapeutics Analyst Ratings
Express News | Poseida Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy
Sector Update: Health Care
Traders Eye Fed Minutes, Driving Muted Premarket Action for US Equity Futures
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of FOMC Meeting Minutes
Today's Pre-Market Movers and Top Ratings | PSTX, LLY, KSS, BBY and More